Oscient Pharmaceuticals Corp. (OSCI) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Oscient Pharmaceuticals Corp. (OSCI)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Ian@SI	7/25/2006 9:33:15 PM
	Read Replies (1) of 1154

A little more on this morning's upgrade. a very aggressive target... 09:47 am Oscient Pharma: JMP Securities upgrades Mkt Outperform to Strong Buy. Target $3.50. Firm upgrades as the acquisition of cardiovascular drug Antara should be immediately accretive for Oscient, it fits well with the target audience for the co's Factive and innovative financing for the acquisition preserves the balance sheet.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next